Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Kidney TransplantType 2 Diabetes
Interventions
DRUG

Administration of sitagliptin

Sitagliptin 100 mg daily for 3 months

Trial Locations (1)

68198-1230

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT00466518 - Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant | Biotech Hunter | Biotech Hunter